Overexpression of bax enhances the radiation sensitivity in human breast cancer cells

被引:29
作者
Sakakura, C
Sweeney, EA
Shirahama, T
Igarashi, Y
Hakomori, SI
Tsujimoto, H
Imanishi, T
Ohgaki, M
Yamazaki, J
Hagiwara, A
Sawai, K
Yamaguchi, T
Takahashi, T
机构
[1] First Department of Surgery, Kyoto Pref. University of Medicine, Kawaramachi-dori
[2] Biomembrane Institute, Seattle, WA 98119
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1997年 / 27卷 / 01期
关键词
breast cancer; radiosensitivity; bax; apoptosis;
D O I
10.1007/BF01366949
中图分类号
R61 [外科手术学];
学科分类号
摘要
Bax-alpha, a splice variant of bax which promotes apoptosis, is expressed in many kinds of untransformed cell lines and breast tissue, whereas only weak or no expression could be detected in breast cancer cell lines and malignant breast tissue. Human breast cancer MCF-7 cells, which have a weak bax gene expression, were stably transfected with pCX2neo bax, encoding human bax and neomycin-resistant genes, and two unique clones (MCF-7/bax-1 and MCF-7/bax-2) were thus generated which expressed different levels of bax-alpha. Sensitivity to ionizing radiation (IR) was examined and each was more sensitive to IR than the parental MCF-7 cells. The degree of enhancement in radiosensitivity was dependent on the expression level of bax, and IR was found to induce intranucleosomal DNA fragmentation in stable transfectant but not in parent cells, thus suggesting that this sensitization is due to apoptosis. We suggest that exogenous bax-alpha expression might therefore be one of the factors determining cellular radiosensitivity in MCF-7 breast cancer cells and may potentially have a therapeutic application by enhancing radiation sensitivity in breast cancer cells.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 14 条
  • [1] EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS
    BARGOU, RC
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    WAGENER, C
    KALLINICH, B
    ROYER, HD
    DORKEN, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) : 854 - 859
  • [2] CHEN M, 1995, CANCER RES, V55, P991
  • [3] KORSMEYER SJ, 1992, CANCER SURV, V15, P105
  • [4] BCL-2 IN NORMAL HUMAN BREAST AND CARCINOMA, ASSOCIATION WITH ESTROGEN RECEPTOR-POSITIVE, EPIDERMAL GROWTH-FACTOR RECEPTOR-NEGATIVE TUMORS AND IN-SITU CANCER
    LEEK, RD
    KAKLAMANIS, L
    PEZZELLA, F
    GATTER, KC
    HARRIS, AL
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 135 - 139
  • [5] MIYASHITA T, 1993, BLOOD, V81, P151
  • [6] NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
  • [7] Nunez Gabriel, 1994, Trends in Cell Biology, V4, P399, DOI 10.1016/0962-8924(94)90053-1
  • [8] OHTA H, 1995, CANCER RES, V55, P691
  • [9] BCL-2 HETERODIMERIZES IN-VIVO WITH A CONSERVED HOMOLOG, BAX, THAT ACCELERATES PROGRAMMED CELL-DEATH
    OLTVAI, ZN
    MILLIMAN, CL
    KORSMEYER, SJ
    [J]. CELL, 1993, 74 (04) : 609 - 619
  • [10] BCL-2 INHIBITS MULTIPLE FORMS OF APOPTOSIS BUT NOT NEGATIVE SELECTION IN THYMOCYTES
    SENTMAN, CL
    SHUTTER, JR
    HOCKENBERY, D
    KANAGAWA, O
    KORSMEYER, SJ
    [J]. CELL, 1991, 67 (05) : 879 - 888